Replies to post #66065 on NanoViricides Inc. (NNVC)

[BonelessCat]

I don't know what world you inhabit, but in my world a "near sure thing" is 90% or better. In my world 50% is 50/50 no matter what. There may be one where better than 50/50 is a near sure thing, but it does not appear to be an evidence-based world.

[Puffer]

you see > 50% and 100% as pretty much the same thing? It's that kind of nonsensical B.S. that makes it impossible to have a rational conversation with you.

[drkazmd65]

I actually figure that there is a 50/50,... 40/60 chance of success here as well in the medium term. Higher probability of success over longer periods of time.

More of a question of when,... how long,... and what particular formulation/application ends up taking control.

My confidence in success here actually took a significant upswing when they came out with the data indicating that the oral form of the viricide worked as well or better in model systems as the IV version,... and both worked better than Tamiflu.

Even IF there ends up being a toxicity problem that needs to be fixed on human internal applications,... the 'Herpes Creme' formulation that was once a major point of conversation here still has a market. Externally applied formulations have a different set of critiera than ones for internal use as regards cell damage toxicity.

The leading potential product is the flucide - given. But that is not the only ligand type and potential formulation that could be put forward.

IMO - too many things would have to go wrong for too long to completely scuttle this company in the long term.

ROI,... and time to see ROI,... more debatable issues.